The clinical utility of the Khorana score in determining risk for venous thromboembolism in patients with gynecologic cancer
Annie Apple(Vanderbilt University), Alaina J. Brown(Vanderbilt University Medical Center), Lauren S. Prescott(Vanderbilt University Medical Center), Kendall C. Shultes(VA Tennessee Valley Healthcare System), Marc Robinson(Vanderbilt University Medical Center)
Cited by 3
Related Papers
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
|Bone Marrow Transplantation|2022|18
Outcomes and Predictors of Early Infection after Heart Transplantation
|Surgical Infections|2018|16
Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation
|Clinical Hematology International|2024|9
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2017|6
Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell Therapy
|Transplantation and Cellular Therapy|2025|3